|
HS Code |
570066 |
| Productname | Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate |
| Casnumber | 934226-94-7 |
| Molecularformula | C7H9BrN2O2 |
| Molecularweight | 233.06 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥ 98% |
| Meltingpoint | 98-102°C |
| Solubility | Soluble in common organic solvents (e.g., DMSO, ethanol) |
| Smiles | CCOC(=O)c1c([nH]n1C)Br |
| Inchikey | QAWYHZHZSNBYLC-UHFFFAOYSA-N |
As an accredited Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years spent working through the challenges of synthetic chemistry have shown me that the distinct quirks of each building block shape outcomes far more than marketing copy ever admits. Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate is one such example: a compound that seems simple on paper, with the usual pyrazole backbone, yet it often delivers beyond basic promise in hands-on synthesis and new molecule design.
This compound, marked by a bromo atom at the five-position and an ethyl ester at carbon four, brings flexibility that’s only grown in value since its introduction to research and pharma labs. You spot the methyl at N-1 and recognize right away—this detail can change the way it fits in small-molecule libraries or fragment-based drug discovery campaigns. Colleagues turning to this pyrazole derivative for the first time sometimes mention how it streamlines their workflow: bromine on the five-position lets them run many cross-coupling methods with reliable yields. The ester group doesn’t just sit there; it brings a functional handle, opening up access to modifications—often overlooked by those who think they need exotic intermediates.
Over the years, I’ve seen too many teams get bogged down chasing high-purity reagents only to find themselves stuck by the quirks of solubility or compatibility. Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate regularly comes up for its crystalline nature, minimal hygroscopicity, and solid thermal stability. Chemists in academia and private industry usually receive this product as a fine powder, white to off-white, with assay results above 98% purity via HPLC. For those working with liquid-phase or solid-phase synthesis, these physical features matter far more than catalog numbers. No one I know enjoys scraping brown goo from a flask; this one isn’t prone to that annoyance.
Looking at the molecular formula—C7H7BrN2O2—doesn’t tell the whole story. It’s the way this compound behaves under standard lab conditions, the ease of handling and precise melting point, that keeps it in steady demand. I’ve heard analytical chemists note the sharpness of its NMR signals, and that clarity gives confidence during method development or routine quality control.
Rather than treat Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate as just a reactant, you’re looking at a bridge between simple benchtop transformations and complex, commercially relevant molecules. Medicinal chemists reach for it when a new heterocycle is called for, envisioning bromo–pyrazole frameworks with the promise of kinase inhibition or CNS activity. I’ve worked with teams developing anti-cancer scaffolds who favor this intermediate for building out SAR quickly; there’s comfort in a reagent that doesn’t complicate purification or lead to intractable byproducts.
Crop scientists have also found value here. Small changes to the pyrazole scaffold often drive big shifts in efficacy or selectivity, and this compound has become a mainstay in lead optimization projects aimed at fungicides or herbicide families. The presence of both ester and bromo groups provides a rare dual lever, making it possible to test multiple routes without tearing through weeks of process re-tooling.
Walk into most synthetic labs, and someone can point you toward a cluttered shelf of pyrazole derivatives. You’ll find the usual suspects—unsubstituted, bi-substituted, fused rings—but many of those lack the distinct promise this compound brings. The bromine at position five, specifically, marks a clear departure from undifferentiated pyrazoles. This opens doors for Suzuki, Stille, or Heck couplings, letting teams build out new molecular diversity without stepping through less reliable halogenation steps.
Comparisons to more basic ethyl pyrazole carboxylates reveal the benefit of selective substitution. Many lack the bromo group and consequently can’t deliver the same access to downstream aryl or alkyl derivatives. Replace that bromo with a chloro or iodo, and you usually inherit headaches—lower yields, trickier purifications, often higher toxicity. So feedback from colleagues is straightforward: ethyl 5-bromo-1-methyl-1H-pyrazole-4-carboxylate slides into existing synthetic plans with less drama, reducing wasted cycles in both screening and scale-up.
Thinking about the methyl at N-1, the difference over the unsubstituted N–H versions is clear. That extra methyl often imparts better solubility in polar aprotic systems, eases crystallization in final product isolation, and occasionally adds essential bulk when the target calls for subtle hydrophobic effects. For fragment-based lead discovery, this detail matters: you gain access to richer SAR without pulling in extraneous impurities.
A lot of stories make sense only after witnessing the small failures that accumulate in daily lab work. I remember struggling to push through a reluctant C–C coupling step using a more basic pyrazole ester, plagued by stubborn side products and inconsistent yields. Moving to the bromo-methyl analog, I saw reaction reliability soar: sharper conversions, easier extractions, and better recovery. That’s no coincidence; the way this compound threads the needle between reactivity and stability frees up time for real research instead of fire-fighting unexpected problems.
Projects with bigger budgets often rely on advanced technology and automation, but even there, the need for consistent, well-behaved building blocks remains. In automated reactor arrays, batch-to-batch consistency saves days, not just hours. My colleagues running high-throughput screens cite this compound as trouble-free—never a red flag in the LCMS or after purification, always ready for next-step derivatization.
I’ve learned to value products that cut down on troubleshooting. Every time a synthetic team can swap one difficult intermediate for something more predictable, resources get freed for design, analysis, or that next creative leap. In the race to deliver new candidates—whether drugs, pesticides, or research probes—a reliable intermediate like this one pays for itself many times over.
Every building block has limits, and ignoring those will only cause trouble. This compound offers above-average compatibility with cross-coupling and condensation reactions, but it’s no magic bullet for every scaffold or synthetic plan. I’ve seen cases where extra purification was necessary to clear minor regioisomers, especially if the supplier’s synthesis route isn’t closely watched. Moisture and oxygen, while not as much enemies here as with some organometallics or boronates, can still chip away at shelf-life over long storage—airtight containers and careful handling solve this, but only if the team stays alert.
Scaling up from tens of milligrams to multi-gram batches surfaced a few nuisance behaviors; extra filtering or caution with solvent choice kept things running smoothly. The ester group’s susceptibility to hydrolysis sits at the back of every synthetic chemist’s mind, especially in basic or strongly acidic solutions. With well-chosen conditions, these risks stay manageable, but skipping that step in planning can eat time and material.
Scientists and buyers look for signals that suppliers uphold responsible practices. Know-how only matters if the reagent you order matches expectations every run, every project. I’ve had good experience with several major vendors offering full traceability and detailed certificates of analysis. Contaminants—heavy metals or residual solvents—rarely pose issues in reputable supply channels. Reproducible quality matters most as research costs climb and regulatory oversight increases.
A few bad actors sell impure or mischaracterized stocks. Once, working through a persistent NMR impurity in an allegedly “high purity” batch, we traced the problem to careless solvent drying on the supplier side. That hiccup cost more lost time than any single bench mistake. A growing segment of the procurement market now looks past price, emphasizing lot-to-lot consistency and transparent documentation. For buyers of Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate, those signals separate trustworthy products from risky choices.
Industry-wide, more companies expect proof of adherence to green chemistry principles and safe handling. Waste treatment, solvent usage, and process energy get close attention during audits. While traditional pyrazole synthesis can generate waste or use hazardous reagents, many producers of this compound now pursue route enhancements—some minimize waste streams or use less hazardous brominating agents.
Buyers ask about the route of synthesis, not just out of curiosity or regulatory obligation, but because they’ve run up against the consequences of poor process choices in downstream development. Reliable players keep in step, updating procedures as safer or more efficient methods get peer-reviewed and validated.
The landscape of drug discovery, agrochemical invention, and specialty chemical design doesn’t stand still. As fragment-based approaches gain traction, interest in heterocycles with orthogonal handles grows. Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate fits squarely in this trend—a fragment that facilitates not just iterative modification but rapid parallel synthesis. Libraries spring up around it; screens run faster, cleaner, closer to design intent.
I’ve watched research teams diversify the pyrazole core in proprietary screening libraries, each time depending on the bromo and ester as launching points for unique substitutions. Downstream, the same product feeds into programs focused on PET imaging agents, targeting ligands, or small molecule catalysts. Market trends point toward continued growth in this class of intermediates as researchers uncover new biological activities linked to tailored pyrazole derivatives.
Each generation of synthetic chemists brings fresh scrutiny to the toolkit they inherit. Where Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate wins favor, it’s usually because of a blend of established reliability and capacity for inventive adaptation. Investment in greener, safer, and even cheaper processes continues—several groups have reported transition-metal-free routes or brighter, single-pot strategies as alternatives to traditional halogenation and esterification. Of course, every shift must clear the same bar for purity, reproducibility, and safe handling that the field now demands.
Users drive these improvements not out of abstract pursuit of “excellence,” but as a response to the practical needs of a field that values real progress over promises. Their feedback—what works, when, and why—pushes suppliers and process chemists to evolve.
One lesson stands above the rest: the best lab results come from combining experience with clear, accessible data. Those considering this compound need more than a paragraph of technical jargon. It means learning to ask how much documentation comes with each lot; whether analytical certificates are clear and complete; and whether supplier support matches the pace of changing research needs. In the push to reduce risk and advance discovery, these elements separate solid choices from avoidable pitfalls.
Those skeptical of yet another “new” building block eventually notice something different here: research-grade lots that arrive right, the first time. Batch-to-batch consistency means the time invested in method development, clean-up, or optimization doesn’t get wasted reworking flawed intermediates. In the current research climate, every saved hour counts for a lot.
Progress demands open sharing of results—both good and bad. By reporting the quirks and workarounds discovered while handling Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate, chemists feed the community with insights, tricks, and cautions that shape future advances. In my own work, it’s often a forum post or internal email that clues a new project into a subtle solubility issue or a shortcut to cleaner reactions.
Every new challenge—regulatory, commercial, scientific—demands tools that pull their weight without drama. This particular intermediate has stayed in circulation not by accident but through its track record in supporting both routine syntheses and the bold pivots that define cutting-edge discovery. It serves as one of those quiet workhorses: not celebrated for flashy properties, but trusted every week, every project, because it does exactly what chemists hope—no more, no less.
What could improve access and utility further? Suppliers have an opportunity to move beyond static catalogs toward dialogues with users. More detailed batch histories, integrated technical support from staff chemists, and a willingness to adjust processes based on validated customer feedback would benefit not only purchasers but also the broader progress of synthetic science. Vigilance in confirming each lot matches the claimed specifications, plus a commitment to transparency over corner-cutting, underpins the best supplier relationships in my experience.
Labs experience real-world benefits when suppliers treat feedback as an asset, not a burden. Openly cataloged performance quirks, solvent compatibilities, and purification tips can shave days off method development. This kind of two-way exchange turns even a familiar intermediate into a renewed source of innovation and reliability as technology and application needs grow.
Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate stands out as more than a line in a reagent handbook. It carries the practical hallmarks of value: reliable behavior in common synthetic settings, flexibility that cuts across medicinal and agrochemical fields, and traceable supply chains tuned to modern expectations. Its methyl, bromo, and ester functionalities do not just adorn its structure—they expand the horizon of possibility for anyone tasked with crafting the next breakthrough molecule. My own years of bench work reinforce its worth as a dependable partner in synthesis.
Years in the lab teach this lesson most clearly: reliable reagents don’t just speed up chemistry—they make better science possible. For every ambitious project looking beyond the status quo, products like Ethyl 5-Bromo-1-Methyl-1H-Pyrazole-4-Carboxylate help push the boundaries by serving as that rare blend of reliability, adaptability, and forward-looking compatibility.